Nisa Investment Advisors
PRCT icon

Nisa Investment Advisors’s Procept Biorobotics PRCT Stock Holding History

Nisa Investment Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.2K Sell
1,205
-38
-3% -$951 ﹤0.01% 2099
2026
Q1 		$31.1K Buy
1,243
+1,213
+4,043% +$34.2K ﹤0.01% 1861
2025
Q4 		$944 Sell
30
-635
-95% -$21.1K ﹤0.01% 2719
2025
Q3 		$23.7K Buy
665
+70
+12% +$3.2K ﹤0.01% 1922
2025
Q2 		$34.3K Sell
595
-505
-46% -$28.6K ﹤0.01% 1706
2025
Q1 		$64.1K Buy
1,100
+270
+33% +$18.4K ﹤0.01% 1519
2024
Q4 		$66.8K Sell
830
-283
-25% -$24.2K ﹤0.01% 1593
2024
Q3 		$89.2K Buy
1,113
+713
+178% +$50.7K ﹤0.01% 1478
2024
Q2 		$24.4K Buy
400
+335
+515% +$19.9K ﹤0.01% 1877
2024
Q1 		$3.21K Buy
65
+35
+117% +$1.67K ﹤0.01% 2166
2023
Q4 		$1.26K Sell
30
-675
-96% -$23K ﹤0.01% 2225
2023
Q3 		$23.1K Hold
705
– – ﹤0.01% 1977
2023
Q2 		$24.9K Buy
705
+682
+2,965% +$22.6K ﹤0.01% 2022
2023
Q1 		$1K Buy
23
+4
+21% +$141 ﹤0.01% 2436
2022
Q4 		$1K Hold
19
– – ﹤0.01% 2484
2022
Q3 		$1K Buy
+19
New +$758 ﹤0.01% 2482

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nisa Investment Advisors's PRCT Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Procept Biorobotics (PRCT) stake by 3.1% in Q2 2026, selling an estimated $951 and leaving 1,205 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2099.

Nisa Investment Advisors first reported a position in PRCT in Q3 2022 and has held it in 16 quarters since. The position peaked at $89.2K in Q3 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Nisa Investment Advisors held 1,205 shares of Procept Biorobotics worth $27.2K as of Q2 2026.
  • Nisa Investment Advisors sold 38 Procept Biorobotics shares in Q2 2026, an estimated $951.
  • Procept Biorobotics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2099 holding.
  • Nisa Investment Advisors first reported a position in Procept Biorobotics in Q3 2022 and has held it in 16 quarters since.
  • Nisa Investment Advisors's Procept Biorobotics position peaked at $89.2K in Q3 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.